EW reports Wednesday, Nov 4, 2026, after the close. After the last 4 reports the stock moved −1.4%, +5.6%, +3.0%, −1.2% the next day.
EW is expected to report on Wednesday, Nov 4, 2026, after the close (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Jul 23, 2026 | 0.74 | 0.78 | −1.4% | +3.7% |
| Apr 23, 2026 | 0.73 | 0.78 | +5.6% | +4.7% |
| Feb 10, 2026 | 0.62 | 0.58 | +3.0% | +2.5% |
| Oct 30, 2025 | 0.59 | 0.67 | −1.2% | −1.2% |
| Jul 24, 2025 | 0.62 | 0.67 | +5.5% | +4.6% |
| Apr 23, 2025 | 0.60 | 0.64 | +6.6% | +7.1% |
| Feb 11, 2025 | 0.55 | 0.59 | +6.9% | +5.3% |
| Oct 24, 2024 | 0.59 | 0.67 | — | — |
Average move the next trading day over the last 7 reports: ±4.3% (5 of 7 up).
EW is in an uptrend, momentum firm. $100 is the level overhead; $93.43 the first support below.
EW at $95.37. Nearest resistance $100.00 (+4.9%). Nearest support $93.43 (−2.0%).
EW chart, levels and analysis · Latest analysis: Edwards Lifesciences (EW) stock analysis, November 3, 2026: New high after trial call, evidence leans positive · Earnings this week
EW is expected to report on Wednesday, Nov 4, 2026, after the close.
EW reports after the close, US Eastern time.
After its report on Jul 23, 2026, EW moved −1.4% the next trading day.
Over the last 7 reports, EW moved 4.3% on average the next trading day, up 5 times out of 7.